HB 1881

In Committee

House

Health care marketplace

Concerning material changes to the operations and governance structure of participants in the health care marketplace.

Introduced (completed)
2
Committee (current stage)
3
Floor Vote (not started)
4
Opposite Chamber (not started)
5
Governor (not started)
6
Signed (not started)

This status may be delayed. See Action History below for the latest updates.

How does a bill become law?

Introduced: The bill is filed and assigned a number.
Committee: A subject-matter committee holds hearings, takes public testimony, and decides whether to advance the bill.
Floor Vote: The full chamber (House or Senate) debates and votes on the bill.
Opposite Chamber: The bill repeats the committee and floor vote process in the other chamber.
Governor: The Governor reviews the bill and decides whether to sign or veto it.
Signed: The bill has been signed into law.

Introduced: February 6, 2025

Last Action: January 12, 2026

Status: H Civil R & Judi

Companion Bill: #5704

View Bill Text (HTML)View Bill Text (PDF)

AI Analysis

This analysis was generated by AI and may contain errors. It is not legal advice. Always refer to the official bill text for authoritative information.

People & CommunitiesBalancedCorporate & Wealthy Interests

This bill strengthens state oversight of health care mergers and acquisitions to protect access, affordability, and equity of care—especially for reproductive, gender-affirming, and end-of-life services. It requires advance notice of major health care transactions and mandates a detailed review of their impact before approval, with ongoing monitoring for five years.

Requires health care entities (hospitals, hospital systems, provider organizations, and certain insurers) to give 90 days’ advance notice to the attorney general and health care authority before completing mergers, acquisitions, or new contracting affiliations.
Establishes a new access, affordability, quality, and equity review that assesses whether a transaction will maintain or improve access to care—including emergency, reproductive, gender-affirming, and end-of-life services—and reduce health disparities.
Prohibits transactions that would reduce access to affordable care for at least five years, unless they meet specific public benefit criteria (e.g., maintain or improve care in underserved areas, reduce costs, or improve health outcomes).
Requires a public hearing and mandates that the health care authority engage with community members, employees, and advocacy groups before making recommendations to the attorney general.
Gives the attorney general authority to approve, approve with conditions, or deny a transaction—and to monitor compliance for up to five years, including through audits and annual reporting.
Imposes civil penalties for noncompliance (up to 10% of transaction value) and allows the attorney general to seek injunctions or legal enforcement if a transaction proceeds without approval or violates conditions.

Who is affected

Health care providers and systems — Hospitals, hospital systems, and provider organizations must submit detailed notices to state agencies before completing mergers, acquisitions, or new contracting affiliations, and may be subject to review, conditions, or denial of the transaction based on impacts to care access and affordability.
Health insurers and third-party administrators — Insurance companies and health plans must be notified of certain transactions involving health care entities and may be impacted if a merger or affiliation changes how services are billed or delivered.
Patients and community members — Patients—especially those in rural areas, low-income individuals, people of color, LGBTQ+ individuals, and those seeking reproductive, gender-affirming, or end-of-life care—may see changes in care availability, cost, or quality depending on how transactions are approved or restricted.
State government agencies — State agencies—the attorney general and health care authority—gain new authority to review, approve (with conditions), or block health care transactions and monitor compliance for up to five years.
Health care workers and unionized staff — Employees of affected health care organizations may face changes in staffing, working conditions, or benefits, and gain a formal role in providing input during the review process.

Effective: 2026-01-01Fiscal impact: The bill authorizes the attorney general and health care authority to charge applicant fees to cover review and monitoring costs, and allows the state to impose civil penalties (up to 10% of transaction value for noncompliance, or up to 1% per day for failure to meet post-approval requirements). Monitoring and enforcement over five years may require additional state staffing or contracted expertise.

Model: Intel/Qwen3-Coder-Next-int4-AutoRoundGenerated: Mar 19, 2026, 7:23 PM

Pro/Con Analysis

Stronger case for benefits

Potential Benefits (4)

The bill explicitly prohibits health care transactions that would detrimentally affect accessible, affordable care for at least five years, requiring that affected communities maintain or improve access to emergency, primary, reproductive, gender-affirming, and end-of-life services. This directly protects everyday Washingtonians, particularly in rural and underserved areas, from losing critical health care options due to consolidation.
HealthcarePeopleRef: Section 9 (Prohibition on detrimental transactions)
The mandatory access, affordability, quality, and equity review requires the health care authority to assess the impact of transactions on health disparities, affordability for Medicaid/Medicare recipients, and access for marginalized populations. This ensures that health care mergers do not exacerbate existing inequities and that the needs of low-income and vulnerable communities are prioritized in the approval process.
HealthcarePeopleRef: Section 12 (Access, affordability, quality, and equity review)
The requirement for public hearings, with notice provided in multiple languages and opportunities for community input, empowers everyday Washingtonians to voice concerns about health care transactions that affect their communities. This transparency and engagement ensure that local residents have a direct say in decisions that impact their access to care.
Public SafetyPeopleRef: Section 11 (Public hearing requirements)
The five-year monitoring period and the authority to conduct on-site audits and impose civil penalties for non-compliance ensure that health care entities adhere to the conditions of their approved transactions. This ongoing oversight protects patients from post-merger service reductions, cost increases, or quality declines that might otherwise go unaddressed.
HealthcareLean peopleRef: Section 14 (Ongoing monitoring and enforcement)

Potential Concerns (3)

The bill mandates that health care entities bear the full cost of five years of state monitoring, audits, and compliance reporting, and imposes civil fines of up to 1% of the transaction value per day for non-compliance. These significant administrative and financial burdens are likely to be passed on to consumers through higher health care prices or reduced service offerings.
Business & EmploymentIndustryRef: Section 14 (Monitoring costs and civil fines)
The requirement for a 90-day advance notice and a multi-stage review process (preliminary and comprehensive) creates substantial regulatory uncertainty and delays for health care entities. This friction may deter beneficial mergers that would improve efficiency, reduce costs, or expand service lines, ultimately limiting the options available to patients.
Business & EmploymentIndustryRef: Section 10 (Approval process and timelines)
The bill removes the previous $10 million Washington revenue threshold for out-of-state entities, meaning any out-of-state health care entity engaging in a material transaction with a Washington entity must comply with the full notice and review process. This increases compliance costs for national and international health care companies, which may reduce their willingness to invest in or partner with Washington providers.
Business & EmploymentLean industryRef: Section 4 (Notice requirements for out-of-state entities)

Who Is Most Affected

Health care providers and systemsNegative Impact
Health care providers and systems face new regulatory burdens, including notice requirements, detailed reviews, and potential transaction denials or conditions. While the bill aims to protect patient access, it may limit their ability to consolidate for efficiency or expand services.
Patients and community membersPositive Impact
Patients, particularly those in rural areas, low-income individuals, and marginalized communities, benefit from protections against service reductions, cost increases, and loss of access to critical care. The bill ensures that health care transactions do not harm their access to affordable, quality care.
State government agenciesMixed Impact
The attorney general and health care authority gain new authority to review, approve, or deny health care transactions and monitor compliance. This expands their regulatory role and requires additional resources for oversight and enforcement.
Health care workers and unionized staffMixed Impact
Health care workers gain a formal role in providing input during the review process, and the bill includes safeguards to maintain staffing capacity and employee rights. However, they may face uncertainty regarding job security and working conditions during transactions.
Health insurers and third-party administratorsMixed Impact
Health insurers and third-party administrators must be notified of certain transactions and may be impacted if a merger changes how services are billed or delivered. The bill's focus on affordability and access may influence their negotiating positions and cost structures.